JT
KNSA icon

Jupiter Topco’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Jupiter Topco’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.5M Buy
+586,177
New +$30.4M 0.02% 500

Other funds holding KNSA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco's KNSA Position: Q2 2026 in Review

Jupiter Topco opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 586,177 shares worth $37.5M. The stake represents 0.02% of the portfolio and ranks #500 among its holdings.

249 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Jupiter Topco held 586,177 shares of Kiniksa Pharmaceuticals worth $37.5M as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.02% of Jupiter Topco's portfolio in Q2 2026, its #500 holding.
  • 249 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.